Drug Manufacturer Gets FDA Approval for Generic Abortion Pill Amid Gov’t Safety Review

HHS Secretary Robert F. Kennedy Jr. clarified the reason for the FDA approval in a social media post.

HHS Provides New Update on Review of Abortion Pill Dangers

The U.S. Department of Health and Human Services (HHS) last week sent a letter to nearly two dozen state attorneys general detailing their active review of the dangerous abortion pill mifepristone.

‘Progressing Apace’: RFK Jr. Says FDA Review of Dangerous Abortion Pill is Underway

Kennedy’s remarks come after new research published by the Ethics and Public Policy Center (EPPC) found a far higher adverse reaction rate associated with mifepristone than previously reported.

‘Serious Risks to Women’: Over 20 Attorneys General Call for Regulation of Abortion Pill

‘[I]n the event the FDA is unable to reinstate the 2011 safety protocols for mifepristone, the FDA should consider withdrawing mifepristone from the market until it completes its review and can decide on a course of action based on objective safety and efficacy criteria,’ the attorneys general wrote.

RFK Jr. Announces HHS Review of Organ Procurement After ‘Horrifying’ Revelations that Some Patients Were Still Alive

While organ donation can be a life-saving gift, malpractice and unethical practices jeopardize the dignity and right to life of donors.